Filing Details

Accession Number:
0001179110-22-000922
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-08 17:13:24
Reporting Period:
2022-02-07
Accepted Time:
2022-02-08 17:13:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551152 Abbvie Inc. ABBV Pharmaceutical Preparations (2834) 320375147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1811896 C Carrie Strom 1 N. Waukegan Road
North Chicago IL 60064
Svp & Pres Global Allerg Aesth No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2022-02-07 4,184 $47.27 44,895 No 4 A Direct
Common Stock, $0.01 Par Value Disposition 2022-02-07 2,396 $141.17 42,499 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Acquisiton 2022-02-07 4,184 $0.00 4,184 $47.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-17 2022-02-17 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.